Recent Updates
Recently added Catalysts
CARM Positive Sentiment Score: 70/100

Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Wednesday, February 5, 2025 1 min read
Key Takeaway: Carisma Therapeutics Inc. will participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 11, 2025. CEO Steven Kelly is set to present at 4:40 pm ET. An audio webcast will be available on the company's Investor Relations webpage. Carisma focuses on macrophage engineering for innovative therapies.

Market Sentiment Analysis

POSITIVE FACTORS

  • Carisma Therapeutics is participating in a notable healthcare conference.
  • The company is recognized for its innovative macrophage-focused therapeutics.
  • The event provides a platform for sharing advancements in treatment paradigms.

Full Press Release Details

PHILADELPHIA,Feb. 5, 2025/PRNewswire/ --Carisma Therapeutics Inc.(Nasdaq:CARM) ("Carisma" or the "Company"), a leader in macrophage-focused therapeutics, today announced thatSteven Kelly, President and Chief Executive Officer, will participate in the Oppenheimer 35thAnnual Healthcare Life Sciences Conference onTuesday, February 11at4:40 pm ET.
An audio webcast of the event will be available on the Company'sInvestor Eventssection of the Investor Relations webpage and will be archived for a limited time following the event.

About Carisma

Carisma Therapeutics is a biopharmaceutical Company pioneering macrophage engineering to develop groundbreaking therapies for fibrosis, cancer, and other diseases. With a strong commitment to patient-centric innovation, Carisma aims to deliver scalable, next-generation solutions that transform treatment paradigms. Carisma is headquartered in Philadelphia, PA. For more information, please visitwww.Carismatx.com.

Investors:Shveta Dighe[email protected]

Media Contact:Julia Stern(763) 350-5223[email protected]

SOURCE Carisma Therapeutics Inc.

Frequently Asked Questions

When will Carisma participate in the Oppenheimer Conference?

Carisma Therapeutics will participate on February 11, 2025.

Who will represent Carisma at the conference?

CEO Steven Kelly will represent Carisma Therapeutics.

What time is Carisma's presentation at the conference?

Carisma's presentation is scheduled for 4:40 pm ET.

Where can I find the audio webcast of the event?

The audio webcast will be available on the Investor Relations webpage.

Tags: CARM Viatris Investor Conferences Healthcare Carisma Therapeutics Oppenheimer Conference macrophage therapeutics healthcare conference
Last updated: Feb 5, 2025